The first data on international multicenter clinical study RheoSTAT-CP0691 on the efficacy and safety of Rheosorbilact® infusion in therapy of purulent peritonitis. prmd [Internet]. 2022 May 30 [cited 2026 Jul. 11];5(1):34-46. Available from: https://perioperative.org.ua/index.php/prtmdc/article/view/103